ABCL-983: Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial
作者
Nirav Niranjan Shah,Peter Borchmann,Tom van Meerten,Pierre Borries,Peter Dreger,László Gopcsa,Pim G. N. J. Mutsaers,Matthias Edinger,Bastian von Tresckow,Peter Neumeister,Normann Steiner,Ulrich Jaeger,Ana Triguero Moreno,Laimonas Griškevičius,Gloria Iacoboni,François Lemonnier,Jaap A. van Doesum,Rimas Orentas,Stefan Miltenyi,Toon Overstijns